Tea, ex trac ts, solutions, and other preparations from plants with a putativ e antihy pergly cemic effect hav e a worldwide utilization in the treatment of diabetes (1 ). Among them, the tea prepared from leav es of jambolan [Syzygium jambos (L.) Alst or Syzyguium cumini (L.) Skeels] is largely used in our city (2) and elsewhere (3). We demonstrated that the tea and extracts from different parts of the plant had no effect in normal rats (4), rats with streptozotocininduced diabetes (5 ), and normal v olunteers (6). A n antihy pergly cemic effect in patients with diabetes, howev er, c ould not be ruled out, since its mechanism of action could depend on specific abnormalities of diabetes in humans.
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In this double-blind, double-dummy clinic al trial, we randomized patients with ty pe 2 diabetes to receiv e a tea prepared from leav es of Syzygium cumini (two grams per liter of water, taken as water substitute) plus placebo tablets, placebo tea (prepared with dried leav es of Imperata braziliensis Trinius) plus gly buride tablets (5 mg twice a day ), or placebo tea plus plac ebo tablets.
Fasting blood glucose lev els decreased significantly in partic ipants treated with gly buride and did not change in those treated with the Syzygium c umini tea and in the participants who rec eiv ed placebos from tea and gly buride (Table 1 ) . BMI, creatinine, γ-glutamy l transferase, alkaline phosfatase, SGOT, SGPT, 24-h glic osuria, 24-h proteinuria, trigly cerides, and total, LDL, and HDL cholesterol did not v ary significantly among the groups.
With this clinical trial, we hav e completed a cy cle of experiments showing that the tea and extracts prepared from leav es of Syzygium cumini are pharmacologically inert. Patients and phy sicians should not rely on the putativ e antihy pergly cemic effect of this tea, and perhaps of other folk medicines, that pretend to hav e suc h an effect. The inv estigation of plants with potential c linical utility could start with a c linical trial testing the effec t of folk preparations in order to isolate the activ e principles of those products that show pharmacological ac tiv ity in this model.
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